Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipid Minimization for PNALD Prevention
NCT02357576Phase 3Completed
- Sponsor
- University of Michigan
- Start
- May 2016
- Primary completion
- Oct 2017
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Intralipid 10% in Parenteral Nutrition Associated Liver Disease (PNALD), cholestasis, sponsored by University of Michigan. Started May 2016; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
Parenteral Nutrition Associated Liver Disease (PNALD)cholestasis
Beyond the preview
Go deeper on NCT02357576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357576.